GNOG.LSE Global X Genomics & Biotechnology UCITS ETF USD Acc GBP

- GBP
No recent price
Total assets
8.06M
Expense ratio
0.49%
Dividend yield
-
1-year return
+49.53%
Holdings
50
Since
2021

Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.

What does GNOG.LSE invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (92.9%)
  • Largest sector: Healthcare (95.1%)
  • Largest region: North America (98.6%)
  • Top 3 holdings: 24.2% of the fund

Asset allocation

  • US stocks 92.9%
  • Non-US stocks 5.0%
  • Cash 0.2%

Top holdings

All holdings, sectors and regions

Global X Genomics & Biotechnology UCITS ETF USD Acc GBP performance

Sharpe ratio 0.76
This year
+48.28%
1 year
+49.53%
3 years
+22.76%
5 years
0.00%

Volatility 27.4% over 1 year and 30.2% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

GNOG.LSE price

Prices on the chart can differ slightly from the closing prices StockSummer shows.